Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Recruiting (1)

Phase

early phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

David Dickens (1)

National Cancer Institute (NCI) (1)

Roswell Park Cancer Institute (1)

Collaborator

Intervention

ascorbate (1)

cisplatin (1)

gemcitabine (1)

ipilimumab (1)

isolated chemotherapeutic lung perfusion (1)

laboratory biomarker analysis (1)

metastasectomy (1)

nivolumab (1)

quality-of-life assessment (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

procedure (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

metastatic bone sarcoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic Bone Sarcoma, Metastatic Malignant Tumor in the Lung, Metastatic Soft Tissue Sarcoma Trial in Buffalo (Cisplatin,

Recruiting

Metastatic Bone Sarcoma
+5 more

Cisplatin
+2 more

Buffalo, New York

Roswell Park Cancer Institute

Jan 24, 2023

Locally Advanced Bone Sarcoma, Locally Advanced Dedifferentiated Liposarcoma, Locally Advanced Gastrointestinal Stromal Tumor

Active, not recruiting

Has Results

Locally Advanced Bone Sarcoma
+20 more

Ipilimumab
+3 more

Anchorage, Alaska
+650 more

Oct 18, 2022

Soft Tissue Sarcoma, Bone Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Iowa City (Ascorbate, Gemcitabine)

Not yet recruiting

Soft Tissue Sarcoma
+5 more

Iowa City, Iowa

University of Iowa Hospitals & Clinics

Sep 16, 2022